Serina Therapeutics (SER) EBIT Margin (2018 - 2025)
Serina Therapeutics (SER) reported EBIT Margin of -18478.46% for FY2025, up 11964.40 percentage points from -30442.86% in FY2024.
Powered by 
Analysis
Serina Therapeutics (SER) EBIT Margin (2018 - 2025) Analysis & Trends
Dating back to FY2017, Serina Therapeutics' EBIT Margin record includes 9 years.
- EBIT Margin has a five-year change of -15680.68 percentage points (FY2020 to FY2025).
- Five-year annual EBIT Margin spans a low of -30442.86% in FY2024 and a high of -99.24% in FY2023.
- According to Business Quant data, EBIT Margin came in at -30442.86% in FY2024 (-30343.62 pp), -99.24% in FY2023 (+20415.47 pp), -20514.71% in FY2022 (-15005.68 pp) and -5509.03% in FY2021 (-2711.24 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn | 28.37% |
| 10 | Serina Therapeutics | 29.17 Mn | -11.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -4,280.77% |
| Sep 30, 2024 | -37,942.86% |
| Jun 30, 2024 | -7,580.39% |
| Mar 31, 2024 | -46,420.00% |
| Dec 31, 2023 | 7.81% |
| Sep 30, 2023 | -5,044.83% |
| Jun 30, 2023 | -13,500.00% |
| Mar 31, 2023 | -3,206.67% |
| Dec 31, 2022 | -22,275.00% |
| Sep 30, 2022 | -17,222.22% |
| Jun 30, 2022 | -13,258.33% |
| Mar 31, 2022 | -41,040.00% |
| Dec 31, 2021 | -6,914.81% |
| Sep 30, 2021 | -6,975.00% |
| Jun 30, 2021 | -5,959.46% |
| Mar 31, 2021 | -3,905.36% |
| Dec 31, 2020 | -1,472.78% |
| Sep 30, 2020 | -3,473.91% |
| Jun 30, 2020 | -5,262.22% |
| Mar 31, 2020 | -3,379.78% |
API Access
Serina Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();